Table 2.

Descriptive characteristics of patients enrolled in the study (n = 32)

Patient characteristic	No.
Sex
Male	21 (65.6%)
Female	11 (34.4%)
Age, median (range)	55.5 years (19-75)
≥50 years	21 (65.6%)
<50 years	11 (34.4%)
Bleeding, median (interquartile range)	5 score points (4.2-6.0)
Moderate bleeding	29 (90.6%)
Severe bleeding	3 (9.4%)
Clinical TNM stage
I	1 (3.1%)
II	6 (18.8%)
III	20 (62.5%)
IV	5 (15.6%)
Histopathology
Adenocarcinoma	32 (100%)
Pathological differentiation
Well differentiated	8 (25.0%)
Moderately differentiated	23 (71.9%)
Poorly differentiated	1 (3.1%)